The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Abiomed; Novo Nordic Foundation</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Boehringer Ingelheim</li></ul>